Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Zhongke Xianxing Medical Technology is a high-tech enterprise that serves as the primary industrialization platform for the National Center for Nanoscience and Technology (NCNST) of the Chinese Academy of Sciences. The company specializes in the research, development, and manufacturing of high-end medical consumables and innovative biomaterials, with a strong focus on nanotechnology applications. Its core product lines include absorbable bone wax for orthopedic surgery, advanced dental restorative materials, and medical adhesives designed for wound management. By translating cutting-edge research from the Chinese Academy of Sciences into clinical applications, the company aims to provide high-quality, domestically produced alternatives to imported medical devices. Zhongke Xianxing Medical maintains state-of-the-art GMP manufacturing facilities to support its growing portfolio of Class II and Class III medical devices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 北京中科先行医疗科技.